Showing results (181-190 of 301) with videos related to

Sort By:
Pageof 31
JACC. Case Reports|July 28, 2021
Use of PCSK9 Inhibitors in Solid Organ Transplantation RecipientsBruce A Warden, Tina Kaufman, Jessica Minnier, et al.
Journal of Clinical Lipidology|August 14, 2018
Relationship of lipoprotein(a) molar concentrations and mass according to lipoprotein(a) thresholds and apolipoprotein(a) isoform sizeSotirios Tsimikas, Sergio Fazio, Nicholas J Viney, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 28, 2014
PMP22 is critical for actin-mediated cellular functions and for establishing lipid raftsSooyeon Lee, Stephanie Amici, Hagai Tavori, et al.
The Journal of Biological Chemistry|May 2, 2018
Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and functionLinda S May-Zhang, Valery Yermalitsky, Jiansheng Huang, et al.
Journal of the American Heart Association|February 14, 2019
Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With EvolocumabMichael D Shapiro, Jessica Minnier, Hagai Tavori, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 26, 2019
Lipoprotein modulation of proteinuric renal injuryYohei Tsuchida, Jianyong Zhong, Tadashi Otsuka, et al.
Journal of the American College of Cardiology|April 19, 2008
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemiaJohn R Guyton, B Greg Brown, Sergio Fazio, et al.
Glia|June 9, 2020
Subcellular diversion of cholesterol by gain- and loss-of-function mutations in PMP22Ye Zhou, David Borchelt, Jodi C Bauson, et al.
Pageof 31